Ed Market

We believe this is where molecularization meets monetization.

Continued Growth

The Erectile Dysfunction (ED) Market

The market is expected to continue its growth. The Americas is the largest market with North America larger than South America due to advanced technology and advanced medical facilities. This factor enables North America to emerge as the largest market on its own. All kinds of advanced medical facilities make North America an ideal market and hence, all kinds of drugs including erectile dysfunction drugs remain in demand.

  • In 1998, the FDA approves Viagra® (sildenafil) for the treatment of ED
  • Viagra’s massive success was practically instantaneous as first year sales yielded ~ US $1 Billion
  • Cialis® and Levitra® are two other oral phosphodiesterase type 5 (PDE5) inhibitors that became available after Viagra®
  • Over the past few decades, the utilization of PDE5 inhibitors in ED has propelled market revenue
  • The global ED market is projected to grow from US $3.7 Billion in 2021 to US $5.9 Billion in 2028

There Are Many Unmet Needs in ED


3 out of 4 men with ED do not seek
treatment due to inconvenience or slow-acting formulations.

Lack of Patient

There is significant stigma around
discussing ED and seeking treatment.

Minimal Patient Education

Patient awareness of ED and need for treatment is limited.

Effects of Food & Drink

Efficacy of the pill is diminished following ingestion of food and drink.

Limited Alternative-Delivery Strategies

No improvements to pill formulations have occurred in the past 2 decades and no non-pill alternative for patients with dysphagia.

No Spontaneity

Current ED treatments take up
to 1 hour for maximum efficacy.

Growing Demand

50% of men over 40 have some form of ED

Physical Causes

High Blood Pressure
Kidney Disease
High Cholesterol
Hormonal Imbalance

Phychological Causes

Loss of Libido
Relationship Issues
Reliance on ED Treatment
Performance Anxiety